Seeing Is Believing
CGON is currently covered by 6 analysts with an average price target of $86.27. This is a potential upside of $24.32 (8.09%) from yesterday's end of day stock price of $79.81.
CG Oncology, Common stock's activity chart (see below) currently has 41 price targets and 55 ratings on display. The stock rating distribution of CGON is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 67.52% with an average time for these price targets to be met of 217.55 days.
Highest price target for CGON is $100, Lowest price target is $70, average price target is $86.27.
Most recent stock forecast was given by GREGORY RENZA from TRUIST on 07-Aug-2026. First documented stock forecast 14-Feb-2024.
Currently out of the existing stock ratings of CGON, 22 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Sep-2024
$85
$5.19 (6.50%)
$82
Buy Since 16-Jul-2025
$79
$-0.81 (-1.01%)
$81
Buy Since 19-Aug-2025
$85
$5.19 (6.50%)
$70
Buy Since 02-May-2025
$96
$24.04 (33.41%)
$91
Andres Y. Maldonado
Buy Since 14-Feb-2024
$100
$28.04 (38.97%)
$80
What is CGON (CG Oncology, Common stock) average time for price targets to be met?
Which analyst has the current highest performing score on CGON (CG Oncology, Common stock) with a proven track record?
Which analyst has the most public recommendations on CGON (CG Oncology, Common stock)?
Which analyst is the currently most bullish on CGON (CG Oncology, Common stock)?
Which analyst is the currently most reserved on CGON (CG Oncology, Common stock)?